FDA panel backs compounded BPC-157, KPV peptides in win for RFK Jr.
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health. Confidential tips can be sent on Signal at lizzylaw.53. In a win for peptide proponents and for health secretary Robert F. Kennedy Jr., an … [Read more…]